The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results from a single-arm, phase II study assessing the efficacy of pembrolizumab plus radiotherapy in metastatic triple negative breast cancer.
 
Alice Ho
Research Funding - Merck Sharp & Dohme (Inst)
 
Christopher Andrew Barker
Consulting or Advisory Role - Elekta; Novartis
Research Funding - Elekta (Inst)
 
Ayca Gucalp
Research Funding - Innocrin Pharma; Pfizer
 
Lizza Lebron-Zapata
No Relationships to Disclose
 
Yong Hannah Wen
No Relationships to Disclose
 
Anh Phung
No Relationships to Disclose
 
Molly Wilgucki
No Relationships to Disclose
 
Micaela Henrich
No Relationships to Disclose
 
Brittany Arnold
No Relationships to Disclose
 
Sujata Patil
No Relationships to Disclose
 
Heather L. McArthur
Consulting or Advisory Role - Celgene; Merck; Spectrum Pharmaceuticals; Syndax
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Peregrine Pharmaceuticals (Inst); ZIOPHARM Oncology (Inst)
Travel, Accommodations, Expenses - Merck; Spectrum Pharmaceuticals